Ointment Packaging
Lohxa
A recent FiercePharma article discussed regulatory action brought to Massachusetts-based drug repackager Lohxa. Apparently the company’s plant was repackaging unit dose drugs with expiration dates of 12 months from repackaging, but had no data to support the dates. Lohxa claimed to have data to support a six-month expiration date, but failed to produce the information. In addition to the expiration date debacle, the company was also dinged for a lack of data related to its equipment cleaning processes. The inspection of the plant happened earlier this year, but the information was only recently posted. The FDA insisted Lohxa resolve the issues as soon as possible.
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
